These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 33906967)

  • 1. Noncanonical crRNAs derived from host transcripts enable multiplexable RNA detection by Cas9.
    Jiao C; Sharma S; Dugar G; Peeck NL; Bischler T; Wimmer F; Yu Y; Barquist L; Schoen C; Kurzai O; Sharma CM; Beisel CL
    Science; 2021 May; 372(6545):941-948. PubMed ID: 33906967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reprogrammed tracrRNAs enable repurposing of RNAs as crRNAs and sequence-specific RNA biosensors.
    Liu Y; Pinto F; Wan X; Yang Z; Peng S; Li M; Cooper JM; Xie Z; French CE; Wang B
    Nat Commun; 2022 Apr; 13(1):1937. PubMed ID: 35410423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The CRISPR-associated DNA-cleaving enzyme Cpf1 also processes precursor CRISPR RNA.
    Fonfara I; Richter H; Bratovič M; Le Rhun A; Charpentier E
    Nature; 2016 Apr; 532(7600):517-21. PubMed ID: 27096362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of RNA Binding Partners of CRISPR-Cas Proteins in Prokaryotes Using RIP-Seq.
    Sharma S; Sharma CM
    Methods Mol Biol; 2022; 2404():111-133. PubMed ID: 34694606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CRISPR RNA-Dependent Binding and Cleavage of Endogenous RNAs by the Campylobacter jejuni Cas9.
    Dugar G; Leenay RT; Eisenbart SK; Bischler T; Aul BU; Beisel CL; Sharma CM
    Mol Cell; 2018 Mar; 69(5):893-905.e7. PubMed ID: 29499139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The tracrRNA and Cas9 families of type II CRISPR-Cas immunity systems.
    Chylinski K; Le Rhun A; Charpentier E
    RNA Biol; 2013 May; 10(5):726-37. PubMed ID: 23563642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The tracrRNA in CRISPR Biology and Technologies.
    Liao C; Beisel CL
    Annu Rev Genet; 2021 Nov; 55():161-181. PubMed ID: 34416117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heavily and fully modified RNAs guide efficient SpyCas9-mediated genome editing.
    Mir A; Alterman JF; Hassler MR; Debacker AJ; Hudgens E; Echeverria D; Brodsky MH; Khvorova A; Watts JK; Sontheimer EJ
    Nat Commun; 2018 Jul; 9(1):2641. PubMed ID: 29980686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CRISPR systems: Novel approaches for detection and combating COVID-19.
    Safari F; Afarid M; Rastegari B; Borhani-Haghighi A; Barekati-Mowahed M; Behzad-Behbahani A
    Virus Res; 2021 Mar; 294():198282. PubMed ID: 33428981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reprogramming TracrRNAs for Multiplexed RNA Detection.
    Jiao C; Beisel CL
    Methods Mol Biol; 2022; 2518():217-235. PubMed ID: 35666448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and Evolution of Cas9 tracrRNAs.
    Dooley SK; Baken EK; Moss WN; Howe A; Young JK
    CRISPR J; 2021 Jun; 4(3):438-447. PubMed ID: 34152211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of trans-cleavage activity of Cas12a with engineered crRNA enables amplified nucleic acid detection.
    Nguyen LT; Smith BM; Jain PK
    Nat Commun; 2020 Sep; 11(1):4906. PubMed ID: 32999292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CRISPR-Cas9 Structures and Mechanisms.
    Jiang F; Doudna JA
    Annu Rev Biophys; 2017 May; 46():505-529. PubMed ID: 28375731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Guide RNA functional modules direct Cas9 activity and orthogonality.
    Briner AE; Donohoue PD; Gomaa AA; Selle K; Slorach EM; Nye CH; Haurwitz RE; Beisel CL; May AP; Barrangou R
    Mol Cell; 2014 Oct; 56(2):333-339. PubMed ID: 25373540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficient Multiple Genome Modifications Induced by the crRNAs, tracrRNA and Cas9 Protein Complex in Zebrafish.
    Kotani H; Taimatsu K; Ohga R; Ota S; Kawahara A
    PLoS One; 2015; 10(5):e0128319. PubMed ID: 26010089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two distinct RNase activities of CRISPR-C2c2 enable guide-RNA processing and RNA detection.
    East-Seletsky A; O'Connell MR; Knight SC; Burstein D; Cate JH; Tjian R; Doudna JA
    Nature; 2016 Oct; 538(7624):270-273. PubMed ID: 27669025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reprogrammed CRISPR-Cas13b suppresses SARS-CoV-2 replication and circumvents its mutational escape through mismatch tolerance.
    Fareh M; Zhao W; Hu W; Casan JML; Kumar A; Symons J; Zerbato JM; Fong D; Voskoboinik I; Ekert PG; Rudraraju R; Purcell DFJ; Lewin SR; Trapani JA
    Nat Commun; 2021 Jul; 12(1):4270. PubMed ID: 34257311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A one-step platform for screening high-efficient and minimal off-target CRISPR/Cas13 crRNAs to eradicate SARS-CoV-2 virus for treatment of COVID-19 patients.
    Li PY; Li SQ; Gao SG; Dong DY
    Med Hypotheses; 2022 Feb; 159():110754. PubMed ID: 35002020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetic characterization of Cas9 enzymes.
    Liu MS; Gong S; Yu HH; Taylor DW; Johnson KA
    Methods Enzymol; 2019; 616():289-311. PubMed ID: 30691648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthetic CRISPR RNA-Cas9-guided genome editing in human cells.
    Rahdar M; McMahon MA; Prakash TP; Swayze EE; Bennett CF; Cleveland DW
    Proc Natl Acad Sci U S A; 2015 Dec; 112(51):E7110-7. PubMed ID: 26589814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.